XINGHE's trip to the Moscow Pharmaceutical Exhibition has come to a successful conclusion with fruitful results.

On November 22nd, 2024, the four-day Moscow Pharmaceutical Exhibition came to a successful conclusion. As an enterprise specializing in the supply of active pharmaceutical ingredients and pharmaceutical excipients, XINGHE shone brightly at this exhibition. It not only successfully expanded its customer resources but also gained an in-depth understanding of the needs of overseas customers, laying a solid foundation for the subsequent export business of its products.

During the exhibition, the professional team members, with full enthusiasm and solid professional knowledge, introduced the company's products in detail to every visiting customer. These products include various high-quality active pharmaceutical ingredients and pharmaceutical excipients, as well as the company's advantages in quality control, research and development innovation, and other aspects.

Excitingly, even before the exhibition ended, the company had already received inquiry emails from multiple potential customers. These inquiries covered many of the company's products, fully demonstrating the strong interest of the overseas market in XINGHE's products. This is not only a high recognition of the company's product quality but also a powerful boost to the company's business expansion in the international pharmaceutical market.

In addition to expanding customer resources, this exhibition also provided an excellent opportunity for XINGHE to gain a deep understanding of the needs of overseas customers. Through face-to-face communication with customers from different countries and regions, the company's team clearly grasped the specific requirements of the overseas market for active pharmaceutical ingredients and pharmaceutical excipients in terms of quality standards, packaging specifications, price ranges, and other aspects. This has extremely important guiding significance for the company to subsequently adjust its product strategies, optimize its product structure, and better adapt to the needs of the overseas market.

Mr. HAN, the person in charge of the company, said, "This trip to the Moscow Pharmaceutical Exhibition is of great significance to us. We have not only successfully promoted our high-quality products to a broader international market and established connections with potential customers but also clarified our future development direction through in-depth communication with customers. We will take this opportunity to further improve our product quality and service level, accelerate the pace of expanding our overseas business, and contribute more to the development of the global pharmaceutical industry."

This trip to the Moscow Pharmaceutical Exhibition is undoubtedly an important milestone on XINGHE's path of international market expansion. It is believed that in the near future, we will see XINGHE's products shine in more international pharmaceutical fields, providing strong support for the health and well-being of global patients.